Anti-C9ORF72 oligonucleotides and related methods
US11629347B2 · kind B2 · utility
1Cited by
27References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 2020 |
| Grant date | Apr 18, 2023 |
| Priority date | — |
| Expiry date | Aug 20, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/53
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure provides antisense compounds, methods, and compositions for silencing C9ORF72 transcripts. The present disclosure provides antisense compounds, methods, and compositions for the treatment, prevention, or amelioration of diseases, disorders, and conditions associated with C9ORF72 in a subject in need thereof. Also contemplated are antisense compounds and methods for the preparation of a medicament for the treatment, prevention, or amelioration of a disease, disorder, or condition associated with C9ORF72.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.